Industry Insider News

Product Trial Confirms Reduction in Pressure Injuries

A clinical trial evaluating DermaTherapy(Standard Textile and Precision Fabrics Group,Cincinnati, OH) technology has found that these specialty linens can help prevent pressure injuries when used in addition to standard of care, according to company officials. The product, a silk-like therapeutic bedding linen with 510(k) clearance by the U.S. Food & Drug Administration, is the only one of its kind to help reduce the likelihood of pressure injuries, officials said. The study of nearly 4,000 high-risk patients in cardiovascular and surgical intensive care units found that the linens led to a significant reduction in pressure injuries due to reduced shear and friction and controlled moisture and heat. According to the study, a 46% reduction of posterior pressure injuries has a healthcare cost savings of nearly $4 million. Visit https://dermatherapy.standardtextile.comfor more information.

Divested Wound Product Acquired by New Company 

Officials at Hydrofera LLC(Manchester, CT) have announced that the company has acquired the Hydroferabrand of business from Hollister^®Inc.(Libertyville, IL). The terms of the sale have not been disclosed. Tom Drury, a principle founder of the purchaser, will serve as the new business’s chief executive officer after serving as the chief operating officer until his retirement in 2016, according to the company. Hollister purchased the recently divested business in 2012 and will continue to provide customers with the wound care product until the purchaser begins distribution, officials said. 

Foam Dressing Significantly Reduces Pressure Ulcers

Officials at Smith & Nephew(Fort Worth, TX) have announced that ALLEVYN Lifewas shown to significantly reduce the onset of pressure ulcers in a recently published study. The randomized controlled trial of 359 elderly hip-fracture patients demonstrated that 4.5% of those who received the multilayer, silicone, adhesive foam dressing in addition to standard care developed a pressure ulcer (a 71% reduction from the 15.4% of patients who received standard care alone). This new study reportedly aligns with other recent research demonstrating the effectiveness of the dressing as part of a comprehensive pressure ulcer prevention protocol. Visit www.smith-nephew.comfor more information.

Clearance Granted for New Proprietary Wound Matrix

The U.S. Food & Drug Administration has cleared Phoenix Wound Matrix(RenovoDerm;Columbus, OH), a fully resorbable synthetic graft similar to the extracellular matrix. The product can be used to treat acute and chronic wounds as well as burns, according to company officials. After several animal studies and cases, the wound matrix demonstrated the ability to stimulate dermal tissue regeneration, including sweat glands and hair follicles. It has also been shown to accelerate the body’s healing response, reduce scar formation, and enhance overall appearance, officials said. Visit www.renovoderm.techfor more information.